FI77877C
(fi)
*
|
1979-04-20 |
1989-05-10 |
Technobiotic Ltd |
Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
|
US4460685A
(en)
*
|
1980-05-29 |
1984-07-17 |
New York University |
Method of enhancing the production of human γ Interferon
|
DE3280127D1
(de)
*
|
1981-03-27 |
1990-04-12 |
Ici Plc |
Genetisch modifizierte mikroorganismen.
|
JPS58146281A
(ja)
*
|
1981-10-19 |
1983-08-31 |
Suntory Ltd |
酵母細胞の形質転換法
|
US4775622A
(en)
*
|
1982-03-08 |
1988-10-04 |
Genentech, Inc. |
Expression, processing and secretion of heterologous protein by yeast
|
BR8307525A
(pt)
*
|
1982-05-19 |
1984-08-21 |
Unilever Nv |
Expressao de proteinas semelhantes a pretrotaumatina em leveduras kluyveromyces
|
GB2125047B
(en)
*
|
1982-08-09 |
1986-02-19 |
Ciba Geigy Ag |
Yeast hybrid vectors and their use for the production of polypeptides
|
IL69202A
(en)
*
|
1982-09-08 |
1991-08-16 |
Smith Kline Rit |
Surface antigen polypeptides of hbv virus produced in yeast and the preparation thereof
|
JPH0716432B2
(ja)
*
|
1982-10-20 |
1995-03-01 |
サントリー株式会社 |
酵母の高発現ベクタープラスミドを用いたペプチドの生産方法
|
EP0116201B1
(de)
*
|
1983-01-12 |
1992-04-22 |
Chiron Corporation |
Sekretorische Expression in Eukaryoten
|
DK172882B1
(da)
*
|
1983-02-07 |
1999-09-06 |
Rothwell Property Ltd |
DNA indeholdende udtrykkelseskontrolregion fra et eukaryot varmechokproteingen, vektor og eukaryot celle indeholdende DNA'e
|
US4876197A
(en)
*
|
1983-02-22 |
1989-10-24 |
Chiron Corporation |
Eukaryotic regulatable transcription
|
CA1341116C
(en)
*
|
1983-02-22 |
2000-10-17 |
Rae Lyn Burke |
Yeast expression systems with vectors having gapdh or pyk promoters and synthesis or foreign protein
|
US4661454A
(en)
*
|
1983-02-28 |
1987-04-28 |
Collaborative Research, Inc. |
GAL1 yeast promoter linked to non galactokinase gene
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
WO1984004330A1
(en)
*
|
1983-04-22 |
1984-11-08 |
Amgen |
Secretion of exogenous polypeptides from yeast
|
US7198919B1
(en)
|
1983-04-25 |
2007-04-03 |
Genentech, Inc. |
Use of alpha factor sequences in yeast expression systems
|
ZA843275B
(en)
*
|
1983-05-05 |
1984-12-24 |
Hoffmann La Roche |
Novel vectors for interferon expression
|
DE3480006D1
(en)
*
|
1983-05-19 |
1989-11-09 |
Unilever Nv |
Improvements in the expression of newly introduced genes in yeast cells
|
WO1984004539A1
(fr)
*
|
1983-05-19 |
1984-11-22 |
Transgene Sa |
Production de la catechol 2,3-oxygenase par des levures, plasmide pour sa mise en oeuvre et application
|
US4870008A
(en)
*
|
1983-08-12 |
1989-09-26 |
Chiron Corporation |
Secretory expression in eukaryotes
|
FR2562090B2
(fr)
*
|
1984-03-27 |
1988-04-08 |
Transgene Sa |
Proteine antigenique de la rage glycosylee
|
FR2552776B1
(fr)
*
|
1983-10-03 |
1986-05-09 |
Transgene Sa |
Vecteurs d'expression d'une proteine antigenique de la rage dans les cellules eucaryotes et leur application a la preparation d'un vaccin
|
WO1985001516A1
(fr)
*
|
1983-10-03 |
1985-04-11 |
Transgene S.A. |
Vecteurs d'expression d'une proteine antigenique de la rage dans les cellules eucaryotes et leur application a la preparation d'un vaccin
|
US5639639A
(en)
*
|
1983-11-02 |
1997-06-17 |
Genzyme Corporation |
Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
|
PH23920A
(en)
*
|
1983-12-20 |
1990-01-23 |
Cetus Corp |
Glucoamylase cdna
|
GB8334261D0
(en)
*
|
1983-12-22 |
1984-02-01 |
Bass Plc |
Fermentation processes
|
EP0154576A1
(de)
*
|
1984-02-06 |
1985-09-11 |
INTERFERON SCIENCES, INC a Delaware Corporation |
Hybrid-Nucleinsäuresequenzen mit tandemartig angeordneten Genen
|
US4626505A
(en)
*
|
1984-02-24 |
1986-12-02 |
E. I. Du Pont De Nemours And Company |
Selectable markers for yeast transformation
|
US4745057A
(en)
*
|
1984-05-18 |
1988-05-17 |
Eli Lilly And Company |
Method, vectors and transformants for high expression of heterologous polypeptides in yeast
|
DK58285D0
(da)
*
|
1984-05-30 |
1985-02-08 |
Novo Industri As |
Peptider samt fremstilling og anvendelse deraf
|
US5683688A
(en)
*
|
1984-05-31 |
1997-11-04 |
Genentech, Inc. |
Unglycosylated recombinant human lymphotoxin polypeptides and compositions
|
SE8403929L
(sv)
*
|
1984-07-31 |
1986-02-21 |
Sten Gatenbeck |
Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas
|
US4752473A
(en)
*
|
1984-10-12 |
1988-06-21 |
The Regents Of The University Of California |
Expression of glycosylated human influenza hemagglutinin proteins
|
US7273695B1
(en)
|
1984-10-31 |
2007-09-25 |
Novartis Vaccines And Diagnostics, Inc. |
HIV immunoassays using synthetic envelope polypeptides
|
US7285271B1
(en)
|
1984-10-31 |
2007-10-23 |
Novartis Vaccines And Diagnostics, Inc. |
Antigenic composition comprising an HIV gag or env polypeptide
|
CA1341482C
(en)
|
1984-10-31 |
2005-05-10 |
Paul A. Luciw |
Process for preparing fragments of aids-associated retroviruses
|
US4812405A
(en)
*
|
1986-02-18 |
1989-03-14 |
Phillips Petroleum Company |
Double auxotrophic mutants of Pichia pastoris and methods for preparation
|
JPS6447380A
(en)
*
|
1987-08-19 |
1989-02-21 |
Agency Ind Science Techn |
Steroid-oxidizing yeast strain
|
US7442525B1
(en)
|
1987-12-24 |
2008-10-28 |
Novartis Vaccines And Diagnostics, Inc. |
Method for expressing HIV polypeptides
|
US5580734A
(en)
*
|
1990-07-13 |
1996-12-03 |
Transkaryotic Therapies, Inc. |
Method of producing a physical map contigous DNA sequences
|
ATE158816T1
(de)
|
1990-11-26 |
1997-10-15 |
Genetics Inst |
Expression von pace in wirtszellen und verfahren zu dessen verwendung
|
FR2686899B1
(fr)
*
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
US5629167A
(en)
|
1994-04-19 |
1997-05-13 |
Biocine S.P.A. |
Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
|
ATE171728T1
(de)
*
|
1994-07-29 |
1998-10-15 |
Teijin Ltd |
Trypsintyp-enzyme, dafür kodierende nukleinsäuresequenz und verfahren zur herstellung des enzymes
|
GB9526733D0
(en)
|
1995-12-30 |
1996-02-28 |
Delta Biotechnology Ltd |
Fusion proteins
|
WO1998013473A1
(en)
|
1996-09-25 |
1998-04-02 |
Vanderbilt University |
Genetically engineered yeast with modified signal peptidase complex
|
MX9605082A
(es)
|
1996-10-24 |
1998-04-30 |
Univ Autonoma De Nuevo Leon |
Levaduras metilotroficas modificadas geneticamente para la produccion y secrecion de hormona de crecimiento humano.
|
BR9813930A
(pt)
|
1997-11-06 |
2006-12-19 |
Chiron Spa |
antìgeno neisserial
|
EP1047784B2
(de)
|
1998-01-14 |
2015-03-18 |
Novartis Vaccines and Diagnostics S.r.l. |
Antigene aus neisseria meningitidis
|
JP2002502977A
(ja)
|
1998-02-04 |
2002-01-29 |
インビトロジェン コーポレイション |
マイクロアレイとその使用
|
GB9808932D0
(en)
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
NZ532665A
(en)
|
1998-05-01 |
2005-11-25 |
Inst Genomic Research |
Neisseria meningitidis antigens and compositions
|
US7081360B2
(en)
*
|
1998-07-28 |
2006-07-25 |
Cadus Technologies, Inc. |
Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties
|
GB9902000D0
(en)
|
1999-01-30 |
1999-03-17 |
Delta Biotechnology Ltd |
Process
|
NZ571167A
(en)
|
1999-04-30 |
2010-05-28 |
Novartis Vaccines & Diagnostic |
Fragments from Neisseria protein ORF 953 and their use in medicaments and diagnostic reagents
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
EP2975127A1
(de)
|
1999-10-29 |
2016-01-20 |
GlaxoSmithKline Biologicals SA |
Neisseria antigenpeptide
|
US6232074B1
(en)
|
1999-12-10 |
2001-05-15 |
Complegen, Inc. |
Functional gene array in yeast
|
EP2275129A3
(de)
|
2000-01-17 |
2013-11-06 |
Novartis Vaccines and Diagnostics S.r.l. |
Ergänzter Außenmembranvesikel-Impfstoff gegen Meningokokken
|
US7780967B2
(en)
|
2000-02-08 |
2010-08-24 |
Allergan, Inc. |
Reduced toxicity Clostridial toxin pharmaceutical compositions
|
US20060269575A1
(en)
*
|
2000-02-08 |
2006-11-30 |
Allergan, Inc. |
Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
|
US20030118598A1
(en)
*
|
2000-02-08 |
2003-06-26 |
Allergan, Inc. |
Clostridial toxin pharmaceutical compositions
|
US8632785B2
(en)
*
|
2000-02-08 |
2014-01-21 |
Allergan, Inc. |
Clostridial toxin pharmaceutical composition containing a gelatin fragment
|
EP1586329A1
(de)
*
|
2000-02-08 |
2005-10-19 |
Allergan, Inc. |
Pharmazeutische Zusammensetzungen mit botulinum Toxin
|
EP1276849A4
(de)
*
|
2000-04-12 |
2004-06-09 |
Human Genome Sciences Inc |
Albumin fusionsproteine
|
US20050100991A1
(en)
*
|
2001-04-12 |
2005-05-12 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
AU5951201A
(en)
|
2000-05-04 |
2001-11-12 |
Univ Yale |
High density protein arrays for screening of protein activity
|
US8697394B2
(en)
*
|
2000-06-28 |
2014-04-15 |
Glycofi, Inc. |
Production of modified glycoproteins having multiple antennary structures
|
US7598055B2
(en)
*
|
2000-06-28 |
2009-10-06 |
Glycofi, Inc. |
N-acetylglucosaminyltransferase III expression in lower eukaryotes
|
US7449308B2
(en)
|
2000-06-28 |
2008-11-11 |
Glycofi, Inc. |
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
|
US7625756B2
(en)
|
2000-06-28 |
2009-12-01 |
GycoFi, Inc. |
Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
|
US7863020B2
(en)
|
2000-06-28 |
2011-01-04 |
Glycofi, Inc. |
Production of sialylated N-glycans in lower eukaryotes
|
KR100787073B1
(ko)
*
|
2000-06-28 |
2007-12-21 |
글리코파이, 인크. |
변형된 당단백질의 제조방법
|
US6737262B1
(en)
*
|
2000-07-11 |
2004-05-18 |
Robert I. Bolla |
Animal feed containing polypeptides
|
JP2002057727A
(ja)
*
|
2000-08-10 |
2002-02-22 |
Hitachi Ltd |
半導体集積回路および光通信モジュール
|
SG165981A1
(en)
|
2000-10-27 |
2010-11-29 |
Chiron Srl |
Nucleic acids and proteins from streptococcus groups a & b
|
US7083787B2
(en)
*
|
2000-11-15 |
2006-08-01 |
Globeimmune, Inc. |
Yeast-dendritic cell vaccines and uses thereof
|
US6861237B2
(en)
|
2000-11-30 |
2005-03-01 |
Novo Nordisk A/S |
Production of heterologous polypeptides in yeast
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
US7507413B2
(en)
*
|
2001-04-12 |
2009-03-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US20050054051A1
(en)
*
|
2001-04-12 |
2005-03-10 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
DE10123980B4
(de)
*
|
2001-05-17 |
2008-01-10 |
Tesa Ag |
Abschlussbandage
|
EP2335723A1
(de)
|
2001-12-12 |
2011-06-22 |
Novartis Vaccines and Diagnostics S.r.l. |
Immunisierung gegen Chlamydia trachomatis
|
EP2277889B1
(de)
|
2001-12-21 |
2014-07-09 |
Human Genome Sciences, Inc. |
Fusionsproteine von Albumin und Interferon beta
|
EP1463752A4
(de)
*
|
2001-12-21 |
2005-07-13 |
Human Genome Sciences Inc |
Albuminfusionsproteine
|
CA2485703A1
(en)
|
2002-05-24 |
2003-12-04 |
Fred W. Wagner |
Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
|
US20040018581A1
(en)
*
|
2002-07-24 |
2004-01-29 |
Pharmacia And Upjohn Company |
Method for discovering substances for inhibiting enzymes
|
PT2279746E
(pt)
|
2002-11-15 |
2013-12-09 |
Novartis Vaccines & Diagnostic |
Proteínas de superfície de neisseria meningitidis
|
US7439042B2
(en)
*
|
2002-12-16 |
2008-10-21 |
Globeimmune, Inc. |
Yeast-based therapeutic for chronic hepatitis C infection
|
US8343502B2
(en)
*
|
2002-12-16 |
2013-01-01 |
Globeimmune, Inc. |
Yeast-based vaccines as immunotherapy
|
KR20140067141A
(ko)
*
|
2002-12-16 |
2014-06-03 |
글로브이뮨 |
면역 요법으로서의 효모계 백신
|
ATE494367T1
(de)
*
|
2002-12-18 |
2011-01-15 |
Hoffmann La Roche |
Rekombinante desoxyribonuclease i aus rinder- pankreas mit hoher spezifischer aktivität
|
EP1433842B1
(de)
|
2002-12-18 |
2011-01-05 |
Roche Diagnostics GmbH |
Rekombinante Desoxyribonuclease I aus Rinder-Pankreas mit hoher spezifischer Aktivität
|
ATE387494T1
(de)
*
|
2002-12-20 |
2008-03-15 |
Hoffmann La Roche |
Hitzelabile desoxyribonuklease i-varianten
|
CA2513213C
(en)
|
2003-01-22 |
2013-07-30 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US7332299B2
(en)
|
2003-02-20 |
2008-02-19 |
Glycofi, Inc. |
Endomannosidases in the modification of glycoproteins in eukaryotes
|
EP1460425A1
(de)
*
|
2003-03-17 |
2004-09-22 |
Boehringer Mannheim Gmbh |
Entglykosilierte Enzymen für Konjugaten
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
US20040248323A1
(en)
|
2003-06-09 |
2004-12-09 |
Protometrix, Inc. |
Methods for conducting assays for enzyme activity on protein microarrays
|
AU2004203649B2
(en)
|
2003-08-12 |
2006-01-12 |
F. Hoffmann-La Roche Ag |
Thermostable Taq polymerase fragment
|
WO2005067368A2
(en)
|
2003-11-21 |
2005-07-28 |
Nps Allelix Corp. |
Production of glucagon like peptide 2 and analogs
|
CA2486195C
(en)
*
|
2003-12-05 |
2012-03-06 |
Stephan Glaser |
Recombinantly expressed carboxypeptidase b and purification thereof
|
GB0329722D0
(en)
|
2003-12-23 |
2004-01-28 |
Delta Biotechnology Ltd |
Modified plasmid and use thereof
|
GB0329681D0
(en)
|
2003-12-23 |
2004-01-28 |
Delta Biotechnology Ltd |
Gene expression technique
|
SG156652A1
(en)
*
|
2004-10-18 |
2009-11-26 |
Globeimmune Inc |
Yeast-based therapeutic for chronic hepatitis c infection
|
AU2005317828A1
(en)
|
2004-12-23 |
2006-06-29 |
Novozymes Delta Limited |
Gene expression technique
|
JP4690787B2
(ja)
*
|
2005-06-14 |
2011-06-01 |
株式会社日立製作所 |
微生物検知チップ及び微生物検知システム並びに微生物検知方法
|
CN101300346B
(zh)
|
2005-06-24 |
2013-04-24 |
帝人制药株式会社 |
新型生理物质nesfatin及其相关物质、以及它们的用途
|
BRPI0613025A2
(pt)
*
|
2005-07-11 |
2010-12-14 |
Globeimmune Inc |
composiÇço para reduzir a resistÊncia a um agente, mÉtodo para a preparaÇço de um veÍculo de levedura e uso da composiÇço
|
ES2370657T3
(es)
*
|
2005-09-14 |
2011-12-21 |
Sanofi-Aventis Deutschland Gmbh |
Escisión de precursores de insulinas mediante una variante de tripsina.
|
EP1934605B1
(de)
*
|
2005-09-22 |
2014-03-26 |
Prosci Incorporated |
In hefemutanten produzierte glykosylierte polypeptide und verwendungsverfahren dafür
|
US20070172503A1
(en)
*
|
2005-12-13 |
2007-07-26 |
Mycologics,Inc. |
Compositions and Methods to Elicit Immune Responses Against Pathogenic Organisms Using Yeast Based Vaccines
|
BRPI0709340A2
(pt)
*
|
2006-03-27 |
2013-04-16 |
Globeimmune Inc |
mutaÇço ras e composiÇÕes e mÉtodos de uso da mesma
|
ATE522541T1
(de)
|
2006-06-09 |
2011-09-15 |
Novartis Ag |
Bakterielle adhäsine konformere
|
WO2008097863A2
(en)
|
2007-02-02 |
2008-08-14 |
Globeimmune, Inc. |
Methods for producing yeast-based vaccines
|
EP2068914A4
(de)
*
|
2007-02-09 |
2011-07-20 |
Medimmune Llc |
Antikörperbibliothekdisplay durch hefezellplasmamembrane
|
US8501167B2
(en)
*
|
2007-03-19 |
2013-08-06 |
Globeimmune, Inc. |
Compositions and methods for targeted ablation of mutational escape of targeted therapies for cancer
|
EP2604623A3
(de)
|
2007-08-08 |
2013-10-02 |
Novozymes Biopharma DK A/S |
Transferrinvarianten und Konjugate
|
US8728489B2
(en)
|
2008-09-19 |
2014-05-20 |
Globeimmune, Inc. |
Immunotherapy for chronic hepatitis C virus infection
|
CN102369213A
(zh)
|
2009-02-06 |
2012-03-07 |
诺维信生物制药丹麦公司 |
纯化方法
|
JP5936112B2
(ja)
|
2009-02-11 |
2016-06-15 |
アルブミディクス アクティーゼルスカブ |
アルブミン変異体及び複合体
|
EP3320915A1
(de)
|
2009-04-17 |
2018-05-16 |
Globeimmune, Inc. |
Kombinationsimmuntherapiezusammensetzungen gegen krebs sowie verfahren
|
CA2774326C
(en)
|
2009-09-14 |
2023-11-07 |
Donald Bellgrau |
Modulation of yeast-based immunotherapy products and responses
|
CN102946900A
(zh)
|
2010-03-11 |
2013-02-27 |
免疫设计公司 |
用于大流行流感的疫苗
|
EP2380905A1
(de)
|
2010-04-19 |
2011-10-26 |
Thrombotargets Europe, S.L. |
Phospholipidangereicherte Vesikel mit Gewebefaktor mit blutstillenden Aktivitäten sowie Verwendungen davon
|
ES2696551T3
(es)
|
2010-12-17 |
2019-01-16 |
Globeimmune Inc |
Composiciones y métodos para el tratamiento o la prevención de la infección por adenovirus-36 humano
|
PE20140844A1
(es)
|
2011-02-12 |
2014-07-14 |
Globeimmune Inc |
Terapeuticos a base de levadura para infeccion de la hepatitis b cronica
|
EP2685995B1
(de)
|
2011-03-17 |
2017-05-03 |
Globeimmune, Inc. |
Immuntherapeutische hefe-brachyury-zusammensetzungen
|
SG195383A1
(en)
|
2011-06-14 |
2013-12-30 |
Globeimmune Inc |
Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection
|
JP6122007B2
(ja)
|
2011-08-17 |
2017-04-26 |
グローブイミューン,インコーポレイテッド |
酵母−muc1免疫療法用組成物およびその使用
|
CN104685360B
(zh)
|
2012-06-26 |
2018-02-13 |
比奥德希克斯股份有限公司 |
用于选择和去选择用产生免疫应答的疗法治疗的癌症患者的质谱方法
|
CA2907560C
(en)
|
2013-03-19 |
2021-12-07 |
Timothy C. Rodell |
Yeast-based immunotherapy for chordoma
|
WO2014160747A2
(en)
|
2013-03-26 |
2014-10-02 |
Globeimmune, Inc. |
Compositions and methods for the treatment or prevention of human immunodeficiency virus infection
|
TWI654200B
(zh)
|
2013-08-30 |
2019-03-21 |
環球免疫公司 |
治療或預防結核病的組合物及方法
|
CA2948803A1
(en)
|
2014-04-11 |
2015-10-15 |
Globeimmune, Inc. |
Yeast-based immunotherapy and type i interferon sensitivity
|
PT3628680T
(pt)
|
2014-06-12 |
2021-10-07 |
Ra Pharmaceuticals Inc |
Modulação da atividade do complemento
|
JP6640229B2
(ja)
|
2015-01-28 |
2020-02-05 |
ラ ファーマシューティカルズ インコーポレイテッドRa Pharmaceuticals,Inc. |
補体活性の変調剤
|
CA2994272C
(en)
|
2015-08-03 |
2023-08-22 |
Globeimmune, Inc. |
Modified yeast-brachyury immunotherapeutic compositions
|
MX2018007352A
(es)
|
2015-12-16 |
2019-05-16 |
Ra Pharmaceuticals Inc |
Moduladores de la actividad del complemento.
|
MX2019006527A
(es)
|
2016-12-07 |
2019-08-01 |
Ra Pharmaceuticals Inc |
Moduladores de la actividad del complemento.
|
EP3622059A4
(de)
*
|
2017-05-10 |
2021-03-10 |
BayMedica, Inc. |
Rekombinante produktionssysteme für prenylierte polyketide der cannabinoid-familie
|
WO2020185543A1
(en)
|
2019-03-08 |
2020-09-17 |
Mevion Medical Systems, Inc. |
Collimator and energy degrader for a particle therapy system
|